Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Audrey Andrews
Authored Items
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Web Exclusives
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Web Exclusives
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Web Exclusives
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Web Exclusives
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Web Exclusives
in
Supportive Care
Last modified: December 11, 2015